Wu HZ et al / Acta Pharmacol Sin 2004 Dec; 25 (12): 1685-1689

Effects of chlorogenic acid, an active compound activating calcineurin, purified from Flos Lonicerae on macrophage1

He-zhen WU, Jing LUO, Yan-xia YIN, Qun WEI2

Department of Biochemistry and Molecular Biology, Beijing Normal University, Beijing 100875, China

1 Project supported by the National Natural Science Foundation of China (No 39930060) the State Key Basic Research and Development Program (No 1998051123) and the Research Fund for the Doctoral Program of Higher Education (20020027006).

2 Correspondence to Qun WEI. Phn 86-10-6220-8197. Fax 86-10-6220-7365. E-mail weiq@bnu.edu.cn

Received 2004-02-05 Accepted 2004-04-19

KEY WORDS calcineurin; macrophage; chlorogenic acid; Flos Lonicerae

ABSTRACT

AIM: To investigate the activation of chlorogenic acid (CHA) purified from Flos Lonicerae to calcineurin and its effects on macrophage functions in vivo and in vitro. METHODS: According to the screening results that Flos Lonicerae could activate calcineurin, the active component which could activate calcineurin was purified from Flos Lonicerae by column chromatography on silica gel and identified as CHA. The activation of CHA on calcineurin had been validated with both p-NPP and 32P-labeled RII peptide as the substrates. The clearance of charcoal particles in normal mice and the cytotoxicity of U937 to MCF-7 were used together to determine the effects of CHA on macrophage functions. RESULTS: CHA could activate calcineurin, and the concentration of CHA on maximal activating calcineurin was 282.5 µmol/L. CHA administration (10 mg/kg, ig×7 d) significantly enhanced the macrophage functions in normal mice. CHA (70.6, 141.2, and 282.5 µmol/L) obviously increased the cytotoxicity of U937 to MCF-7. CONCLUSION: CHA could activate calcineurin and enhance the macrophage functions in vivo and in vitro, and its functions in vivo may be realized via the signal pathways of calcineurin.

INTRODUCTION

The phosphorylation-dephosphorylation of signal transduction protein plays a critical role in cell immune responses. Calcineurin, a Ca2+ and calmodulin (CaM)-dependent serine/threonine protein phosphatase[1,2], is an important mediator in signal transmission, connecting the Ca2+-dependent signaling to a wide variety of cellular responses. The studies on biological roles of calcineurin have progressed to the important discovery that it is the common target of the immunosuppressant drugs cyclosporin A (CsA) and FK506[3]. They are pharmacological reagents that have been used to demonstrate calcineurin as a major player in Ca2+-dependent eukaryotic signal transduction pathways. During the T cell activation, upon the binding of antigen to T cell receptor (TCR), intracellular Ca2+ is elevated through the actions of protein tyrosine kinases and phospholipase C. Calcineurin is activated by binding Ca2+/CaM, and dephosphorylates the cytosolic forms of the NF-ATc transcription factors. The dephosphorylated NF-ATc transcription factors translocate to the nucleus, where they bind, either alone or in cooperation with AP-1 family members, to specific cis elements in the promoter/enhancer regions of cytokine genes, such as interleukin-2 (IL-2). This pathway makes an important contribution to the induction of IL-2 gene transcription, a hallmark of T cell activation[4]. CsA and FK506 inhibit the activity of calcineurin after forming complexes with cytoplasmic immunophilins, cyclophilins, and FKBP12, respectively[5-7]. These immunophilin-immunosuppressant complexes bind calcineurin and inhibit its functions by sterically hindering the access of substrates to the catalytic site. The inhibition of calcineurin is related to the adverse side effects of CsA and FK506[8,9].

Although calcineurin plays a critical role in cell immune responses, little is known about the functions of calcineurin in macrophages. Recently several studies have reported the important effects on macrophages by blocking calcineurin with CsA or FK506, such as macrophage proliferation and macrophage effector functions[10,11].

Except for some metal ions, such as Ca2+, Mn2+ and Ni2+[2], little attention has been paid to the activator of calcineurin. Based on the characteristics of calcineu-rin, an effective molecular screening model was established in our laboratory [12]. A lot of materials have been screened with this model, a few of Chinese traditional medicines, which could activate calcineurin and was related to immunity, have been obtained in our laboratory[13]. The active component which could activate calcineurin was purified from Flos Lonicerae (one of the activators we got) and identified as chlorogenic acid (CHA). Substrates p-NPP and 32P-labelled RII peptide were used to validate the activation of CHA to calcineurin. Due to the connection between calcineurin and macrophages[10,11], the clearance of charcoal particles in normal mice and the cytotoxicity of U937 to MCF-7 were together used to determine the effects of CHA on the macrophage functions in vivo and in vitro.

MATERIALS AND METHODS

Enzyme and reagent RII peptide was purchased from Biomol Lab. p-Nitrophenyl-phosphatase (p-NPP) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) were purchased from Sigma. [¦Ã-32P]-ATP was purchased from Beijing Furi Biology Engineering Corp. cAMP-dependent protein kinase and catalytic subunits were purchased from Promega. U937 (Human monocytic cells) and MCF-7 were provided by Research Institute of Cellular Biology of Beijing Normal University. RPMI-1640 and DMEM were purchased from Hyclone Corp. FCS was purchased from Yuanheng Shengma Biotechnology Research Center of Beijing. All other reagents used were of analytical grade.

Material Flos Lonicerae was purchased from Beijing Tongrentang Pharmaceutical Group and identified as Lonicera japonica Thunb. The voucher sample was deposited in the department of biochemistry and molecular biology of Beijing Normal University.

Extraction and isolation Flos Lonicerae (3.0 kg) was extracted with EtOH:H2O (75:25, v:v) and concentrated in vacuum. The concentrated extract was dissolved in water and adjusted to pH 9-10 with NH3·H2O, then partitioned with chloroform (CHCl3) for 4 times. After that, the pH of the water layer was adjusted to 3-4 with HCl, and then partitioned with ethyl acetate (EtOAc) for 4 times. The activation assay showed that the EtOAc layer was the major activation partition; and then it was evaporated to dry in vacuum and carefully subjected to silica gel column chromatography and fractionated with an EtOAc-MeOH solvent system. EtOAc:MeOH (100:5) fractions, showing stronger activation on calcineurin, were further purified by re-crystallizing with CHCl3 and MeOH, respectively. A white crystal was obtained and its structure was identified as CHA by means of 1HNMR/13CNMR, MS, and IR.

Chemical structure of CHA

Assay of CHA to calcineurin activation Calcineurin and calmodulin were isolated from fresh bovine brain as previously described[14]. The activation assay of CHA to calcineurin was assayed by using p-NPP as substrate[15]. Ten µL enzyme solution and 10 µL CHA solution or 10 µL water (as lack-CHA control) were mixed and pre-incubated in ice bath for 10 min, then added 180 µL assaying buffer (Tris-HCl 50 mmol/L pH 7.4, DTT 0.5 mmol/L, CaCl2 0.2 mmol/L, MnCl2 0.5 mmol/L, BSA 0.2 g/L, calmodulin 0.3 µmol/L, and p-NPP 20 mmol/L) and incubated in water-bath at 30 ºC for 20 min in a final volume of 200 µL; the reaction was terminated by adding 1.8 mL solution (Na2CO3 0.5 mol/L, edetic acid 20 mmol/L), and then the absorbance at 410 nm was measured by using a lack-CHA/enzyme control; and measured values were corrected by a lack-enzyme control. The units (U) of calcineurin activity are defined as nanomoles of p-NPP hydrolyzed per milligram enzyme per minute at 30 ºC.

When assaying phosphatase activity with substrate 32P-labeled RII peptide[16], the experimental protocol was, according to the previous description[17], modified as below: calcineurin (1 µL) and CHA solution (1 µL) were mixed and pre-incubated for 10 min in ice bath, then added 18 µL assaying buffer with 20 µmol 32P-labelled RII peptide and incubated in water bath at 30 ºC for 20 min. Finally, 180 µL 83.3 mmol H3PO4 was added to terminate the reactions. Total 175 µL reaction mixture was subjected to a cation-exchanged column for separating 32P-released from RII peptide and quantitated by liquid scintillation spectrometry. The units (U) of protein phosphatase activity are defined as 32P nanomoles of RII peptide released per milligram enzyme per minute at 30 ºC.

Clearance of charcoal particles Male Kunming mice (18-22g, Grade II, Certificate No SCXK11-02-0004. Experimental Animals Center of Peking University, Beijing, China) were housed under controlled conditions (temperature: 20±1 ºC and lighting: 08:00 AM-20:00 PM) with food and water ad libitum, except during experiments. Animals were treated in accordance with current laws and the NIH Guide for Care and Use of Laboratory Animals. CHA was dissolved in saline prior to administration at doses of 5, 10, and 20 mg/kg and orally administered every day at the same time for 7 d. The oral volume was kept constant at 20 mL/kg irrespective of dose. From d 8 after the first administration, mice were injected iv with 1:10 diluted Yidege ink 10 mL/kg. At 1 min (T1) and 12 min (T2), blood 20 µL was taken from retro-ocular venous plexus and resolved in 2 ml 0.1% Na2CO3 solution. The absorbance (A) was measured at 675 nm with 720 spectrophotometer[24]. The clearance rate K and clearance index a were calculated:

K=(lgC1-lgC2 )/(T1-T2)

a=(W/WLS)·K1/3

(W: weight of rat; WLS: liver weight+spleen weight; C1, C2: the concentration of charcoal particles in blood at T1 and T2, respectively)

Cell Culture and experimental treatment Human monocytic cells (U937) were used as effector cells (E), while human breast cancer cells (MCF-7) were used as target cells (T). U937 cells and MCF-7 cells were incubated in 96-well plate-bottom at a ratio of (20:1) with mixed culture medium of 90 % RPMI-1640 and 10 % FCS. CHA was dissolved in this mixed culture medium and added into the well-cultured U937 and MCF-7. The final concentrations of CHA were 70.6, 141.2, and 282.5 µmol/L, respectively. Controls were established in every group. The cells were incubated for 24 h at 37 ºC, 5 % CO2 and 90 % relative humidity. Then the U937 cell with the medium was aspirated from the wells carefully, and the 10 µL MTT ( 5 mg/mL) and 100 µL of fresh medium were added into those wells. Cultured at the previous conditions for 4 h, the medium was aspirated and 100 µL ethanol was added into every well. After 20 min, the absorbance was determined with an ELISA reader at a measured wavelength of 570 nm and a referenced wavelength of 630 nm[18].

Statistical analysis The data were expressed as mean±SD. Statistical analysis of the data for multiple comparisons was performed by one-way ANOVA followed by the Dunnett's test.

RESULTS

Activation of CHA to calcineurin The activation of CHA to calcineurin was investigated by using p-NPP as the substrate. CHA significantly activated calcineurin at concentration ranges of 2.25-1412.4 µmol/L. The maximal activation concentration of CHA to calcineurin was 282.5 µmol/L (Tab 1).

Tab 1. Effects of CHA on calcineurin with p-NPP as substrate. Three separated experiments were accomplished for each concentration and triplicate in every assay. n=3. Mean±SD. cP<0.01 vs calcineurin control.

CHA

Calcineurin activity/

Comparative

concentration/

nmol¡¤min-1¡¤mg-1

activation of CHA

µmol¡¤L-1

 

to calcineurin/%

0 (calcineurin control)

544¡À23

100.0

2.25

572¡À10

105.2

11.3

593¡À11c

109.0

56.5

654¡À11c

120.2

282.5

719¡À6 c

132.2

1412.4

675¡À5 c

124.1

 

It was reported that the inhibition of immunosuppressant drugs to calcineurin in vitro only occurred when a physiological substrate, such as phosphocasein or phospho-RII peptide, was used to assay the calcineurin activity, but this inhibition would be presented to activation when using p-NPP as substrate[19,20]. To validate the activation of CHA to calcineurin, the activation of CHA to calcineurin with the substrate 32P-labelled RII peptide was designed and assayed. The pre-assayed results with substrate 32P-labelled RII peptide showed that the maximal activation concentration of CHA to calcineurin was 282 µmol/L (data not shown). At this CHA concentration, three independent experiments had been conducted to investigate the activation of CHA on calcineurin. The results showed that CHA could significantly up-regulate the activity of calcineurin from 388.8 U to 485.4 U (P<0.01). The comparative activation of CHA to calcineurin was 24.9 %.

Effects of CHA on clearance of charcoal particles in normal mice Effects of CHA on clearance of charcoal particles in normal mice were shown in Tab 2. CHA produced a significant increase on K and a at 10 mg/kg.

Tab 2. Effects of CHA on clearance of charcoal particles in normal mice. n=10. Mean±SD. bP<0.05, eP<0.01 vs saline.

Treatment/mg¡¤kg-1

103¡ÁClearance rate (K)

Clearance index (a)

Saline

29.4¡À8.8

3.61¡À0.32

CHA 5

24.3¡À3.8

3.59¡À0.28

CHA 10

37.2¡À9.8b

4.47¡À0.19e

CHA 20

26.6¡À3.8

3.75¡À0.19

Effects of CHA on cytotoxicity of U937 The effects of CHA on cytotoxicity of macrophage were assayed by using U937 as effector cell and MCF-7 as target cell. CHA significantly enhanced the cytotoxicity of U937 to MCF-7 at 70.6, 141.2, and 282.5 µmol/L (Tab 3).

Tab 3. Effects of CHA on cytotoxicity of U937 to MCF-7. n=4. Mean±SD. bP<0.05, cP<0.01 vs CHA control.

CHA/µmol¡¤L-1

OD570nm

          

CHA alone

CHA+U937

    0

0.77¡À0.04

0.54¡À0.10

  70.6

0.75¡À0.06

0.36¡À0.07c

141.2

0.72¡À0.05b

0.24¡À0.04c

282.5

0.71¡À0.05c

0.24¡À0.10c

DISCUSSION

Calcineurin plays an important role on regulation of immunity through activating T cells. Those functions of calcineurin on immunity regulation have been proved through inhibiting the activity of calcineurin with immunosuppressant, such as CsA and FK506. But the classical immunosuppressants have a practical defect because of their high toxicity. In our laboratory, it had been found that immunosuppressive components from traditional Chinese medicines, ZIP1, could directly inhibit calcineurin without drug binding protein[13] and provide a new clue for the further development of immunosuppressants with lower toxicity. Then, the modulators screened from traditional Chinese medicines may bring extensive attention on immunity.

Macrophages function critically in the immune system. They behave as regulators of homeostasis and as effector cells in infection, wound healing and tumor growth[21]. Clearance of charcoal particles is a classical experiment for testing the functions of macrophage on foreign substance in vivo. And the macrophage cytotoxicity of U937 to MCF-7 could explain the cytotoxic functions of macrophage on tumor cells. In the present study, it has been found that during the traditional Chinese medicines screening, the phosphatase activity using p-NPP as a substrate was coincident with the result using 32P-labelled RII peptide as a substrate. Our results clearly demonstrate that CHA activates calcineurin and increases the ability of macrophage functions. It may be absorbed by macrophage and activate its calcineurin. The activated calcineurin plays subtle roles in immune systems. The calcineurin-mediated effects of CHA on macrophage are just one possible explanation for the observed results[22,23].

In a word, CHA could activate calcineurin, and the administration of CHA significantly improves the functions of macrophage in normal mice. The reason remains somewhat speculative, it is thus imperative to investigate the changes of activity and content of calcineurin. Our present study provides evidence for activators screening from Chinese herbal medicine. More important is that calcineurin is an efficient enzyme for screening[24]. The natural products obtained from our screening offer the clues for further development of leading compounds.

REFERENCES

1 Erin N, Bronson SK, Billingsley ML. Calcium-dependent interaction of calcineurin with Bcl-2 in neuronal tissue. Neuroscience 2003; 117: 541-55.

2 Rusank F, Mertz P. Calcineurin: form and function. Physiol Rev. 2000; 80: 1483-521.

3 Liu J, Farmer Jr JD, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991; 66: 807-15.

4 Cho CS, Elkahwaji J, Chang Z, Scheunemann TL, Manthei ER, Hamawy MM. Modulation of the electrophoretic mobility of the linker for activation of T cells (LAT) by the calcineurin inhibitors CsA and FK506: LAT is a potential substrate for PKC and calcineurin signaling pathways. Cell Signal 2003; 15: 85-93.

5 Kissinger CR, Parge HE, Knighton DR, Lewis CT, Pelletier LA, Tempczyk A, et al. Crystal structure of human calcine-urin and the human FKBP12-FK506-calcineurin complex. Nature 1995; 378: 641-4.

6 Clipstone NA, Fiorentino DF, Crabtree GR. Molecular analysis of the interaction of calcineurin with drug-immunophilin complexes. J Biol Chem 1994; 269: 26431-37.

7 Feske S, Okamura H, Hogan PG, Rao A. Ca2+/calcineurin signaling in cells of the immune system. Biochem Biophys Res Commun 2003; 311: 1117-32.

8 Luo C, Shaw KT, Raghavan A, Aramburu J, Garcia-Cozar F, Perrino BA, et al. Interaction of calcineurin with a domain of the transcription factor NFAT1 that controls nuclear import. Proc Natl Acad Sci USA 1996; 93: 8907-12.

9 Griffith JP, Kim JL, Kim EE, Sintchak MD, Thomson JA, Fitzgibbon MJ, et al. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell 1995; 82: 507-22.

10 Conboy IM, Manoli D, Mhaiskar V, Jones PP. Calcineurin and vacuolar-type H+-ATPase modulate macrophage effector functions. Proc Natl Acad Sci USA 1999; 96: 6324-29.

11 Comalada M, Valledor AF, Sanchez-Till E, Umbert I, Xaus J, Celada A. Macrophage colony-stimulating factor-dependent macrophage proliferation is mediated through a calcineurin- independent but immunophilin-dependent mechanism that mediates the activation of external regulated kinases. Eur J immunol 2003; 33: 3091-100.

12 Yan LJ, Wei Q. High activity of the calcineurin A subunit with a V314 deletion. Biol Chem 1999; 380: 1281-85.

13 Yan LJ, Yu CJ, Wei Q. Effect of different immunosuppressive drugs on calcineurin and its mutants. Sci China C Life Sci 2000; 43: 68-74.

14 Wei Q, Lu ZJ, Xiao FX, Xing LZ, Li DH. A useful method of calcineurin, calmodulin, and other calcium binding proteins. Chin Biochem J 1993; 9: 6-10.

15 Wei Q, Lee EYC. Expression and reconstitution of calcineurin A and B subunits. Biochem Mol Biol Intern 1997; 40: 169-77.

16 Perrino BA, Fong YL, Brickey DA, Saitoh Y, Ushioll Y, Fukunagall K, et al. Characterization of the phosphatase activity of baculovius-expressed calcineurin A isoform. J Biol Chem 1992; 267: 15965-69.

17 Perrino BA, Ng LY, Soderling TR. Calcium regulation calcineurin phosphatase activity by the B subunit and calmodulin. J Biol Chem 1995; 270: 340-46.

18 Carmichael J, Degraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987; 47: 936-42.

19 Liu J, Farmer JD JR, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991; 66: 807-15.

20 Swanson SK-H, Born T, Zydowsky LD, Cho H, Chang HY, Walsh CT, et al. Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B. Proc Natl Acad Sci USA 1992; 89: 3741-45.

21 Xaus J, Comalada M, Valledor AF, Cardó M, Herrero C, Soler C, et al. Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis. Immuno-biology 2001; 204: 543-50.

22 Zhao HW, Li YH, Zhu YN, Weng SA, Zhang Y, Ge SW. Effect of brucine on mouse nonspecific immune responses. Acta Pharmacol Sin 1997; 18: 468-70.

23 Xing JB, Li HJ, Li P, Liu Y. Studies on chemical constituents in dried buds of Lonicera japonica Thunb. Chin J New Drug. 2002; 11: 856-59.

24 Luo J, Yin JH, Wu HZ, Wei Q. Extract from Fructus cannabis activating calcineurin improved learning and memory in mice with chemical drug-induced dysmnesia. Acta Pharmacol Sin 2003; 24: 1137-42.